Section 3(d) strikes again in GSK India patent defeat

02-08-2013

Section 3(d) strikes again in GSK India patent defeat

GlaxoSmithKline / Flickr.com

India’s Intellectual Property Appeal Board (IPAB) has revoked a patent covering GlaxoSmithKline’s (GSK) breast cancer drug Tykerb, in the latest blow to western pharmaceutical companies in India.


glaxosmithkline, section 3(d), ipab, Tykerb, tyverb, lapatinib,

WIPR